Literature DB >> 16333399

Sildenafil--a possible treatment for acute pulmonary hypertension during cardiac surgery.

Wendy Wheeler1, Shelly Hayes, Ngo Nguyen, Anthony M Cilla, Joseph Rybowicz, Comeco C Jones, Michael A E Ramsay, Shelley A Hall, Dan Meyer, John Capehart, Michael E Jessen, Steves Ring.   

Abstract

Entities:  

Year:  2002        PMID： 16333399      PMCID： PMC1276328          DOI： 10.1080/08998280.2002.11927806

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  29 in total

1.  Viagra for impotence of pulmonary vasodilator therapy?

Authors:  R F Lodato
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

2.  Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn.

Authors:  H Christou; L J Van Marter; D L Wessel; E N Allred; J W Kane; J E Thompson; A R Stark; S Kourembanas
Journal:  Crit Care Med       Date:  2000-11       Impact factor: 7.598

3.  Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension.

Authors:  D Abrams; I Schulze-Neick; A G Magee
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

4.  Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension.

Authors:  H Wilkens; A Guth; J König; N Forestier; B Cremers; B Hennen; M Böhm; G W Sybrecht
Journal:  Circulation       Date:  2001-09-11       Impact factor: 29.690

5.  Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension.

Authors:  F Ichinose; J Erana-Garcia; J Hromi; Y Raveh; R Jones; L Krim; M W Clark; J D Winkler; K D Bloch; W M Zapol
Journal:  Crit Care Med       Date:  2001-05       Impact factor: 7.598

6.  Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

Authors:  V V McLaughlin; D E Genthner; M M Panella; S Rich
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

Review 7.  Chronic cor pulmonale. Etiology and management.

Authors:  H I Palevsky; A P Fishman
Journal:  JAMA       Date:  1990-05-02       Impact factor: 56.272

8.  The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.

Authors:  S Rich; E Kaufmann; P S Levy
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245

Review 9.  Primary pulmonary hypertension.

Authors:  S P Gaine; L J Rubin
Journal:  Lancet       Date:  1998-08-29       Impact factor: 79.321

10.  Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; D Saleh
Journal:  N Engl J Med       Date:  1995-07-27       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.